Validation of GFRNMR at Mayo Clinic

Overview

About this study

The purpose of this study is the diagnostic validation of GFRNMR using a prospective single center study design in the actual daily routine setting of clinical practice.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patient is scheduled for renal iothalamate renal clearance measurement.
Age ≥ 18 years.
Patient information received, read, understood, and signed.

Exclusion Criteria:

Individuals < 18 years.
Patients under haemodialysis within 7 days before renal iothalamate clearance measurement.
Patients under peritoneal dialysis within 7 days before renal iothalamate clearance measurement.

Eligibility last updated 8/20/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator John Lieske, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

John Lieske, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials